Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent, newly approved cholesterol drugs could "wreak financial havoc" among its...
As dietary sodium levels go up over time, so does the risk for high blood pressure, suggests a new study that followed more than 4,000 adults in Japan for four years.
Dr. James Jude, one of the experts credited with pioneering life-saving cardiopulmonary resuscitation, has died. He was 87.
A powerful new class of drugs promises to change the management of heart disease for high-risk patients who struggle to get their cholesterol levels under control—a group that numbers in the millions.
Two of the most anticipated new heart drugs to be launched in recent years have been priced well above analyst expectations, fuelling the debate about whether modern medicines cost too much.
The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.
The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a...
Many hospitals overestimate how quickly they give stroke patients a clot-busting treatment designed to help minimize damage, a U.S. study suggests.
Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.